Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune Neoral.
Chu
S H
SH
Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taipei, Taiwan.
Pang
S T
ST
Chiang
Y J
YJ
Chuang
C K
CK
Chen
H W
HW
Chen
C S
CS
Chou
C C
CC
Huang
C C
CC
D000284:Administration, Oral; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001794:Blood Pressure; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D004304:Dosage Forms; D004305:Dose-Response Relationship, Drug; D004655:Emulsions; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D014527:Uric Acid / Q000097:blood
D004304:Dosage Forms; D004655:Emulsions; D007166:Immunosuppressive Agents; D014527:Uric Acid; D016572:Cyclosporine; D002784:Cholesterol; D003404:Creatinine; D000410:Alanine Transaminase